University of Birmingham Expression of Idh1(R132H) in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis

Citation for published version (Harvard): Bardella, C, Al-Dalahmah, O, Krell, D, Brazauskas, P, Al-Qahtani, K, Tomkova, M, Adam, J, Serres, S, Lockstone, H, Freeman-Mills, L, Pfeffer, I, Sibson, N, Goldin, R, Schuster-Böeckler, B, Pollard, PJ, Soga, T, McCullagh, JS, Schofield, CJ, Mulholland, P, Ansorge, O, Kriaucionis, S, Ratcliffe, PJ, Szele, FG, Tomlinson, I & Tomlinson, I 2016, 'Expression of Idh1(R132H) in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis', Cancer Cell, vol. 30, no. 4, pp. 578-594. https://doi.org/10.1016/j.ccell.2016.08.017

[1]  Steven J. M. Jones,et al.  The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.

[2]  Scott N. Hwang,et al.  Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria , 2015, Journal of Inherited Metabolic Disease.

[3]  B. Alman,et al.  Mutant IDH is sufficient to initiate enchondromatosis in mice , 2015, Proceedings of the National Academy of Sciences.

[4]  Hiromichi Suzuki,et al.  Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas , 2014, Journal of Neuro-Oncology.

[5]  C. Schofield,et al.  Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases , 2014, Nature Communications.

[6]  Travis J Cohoon,et al.  D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice , 2014, Genes & development.

[7]  M. Ross,et al.  Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2 , 2013, Nature Communications.

[8]  Mitchel S. Berger,et al.  Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme , 2013, Front. Oncol..

[9]  William A. Pastor,et al.  TETonic shift: biological roles of TET proteins in DNA demethylation and transcription , 2013, Nature Reviews Molecular Cell Biology.

[10]  W. Kaelin,et al.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. , 2013, Genes & development.

[11]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[12]  S. Inoue,et al.  D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. , 2012, Genes & development.

[13]  Hai Yan,et al.  A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation , 2012, Genome research.

[14]  G. Reifenberger,et al.  IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics , 2012, Nature.

[15]  D. Ellison,et al.  Cerebral Neoplasms in L-2 Hydroxyglutaric Aciduria: 3 New Cases and Meta-Analysis of Literature Data , 2012, American Journal of Neuroradiology.

[16]  S. Berger,et al.  IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.

[17]  A. Bordey,et al.  Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion. , 2012, Human molecular genetics.

[18]  A. Futreal,et al.  Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2 , 2011, Nature Genetics.

[19]  R. Sciot,et al.  Somatic mosaic IDH1 or IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome , 2011, Nature Genetics.

[20]  J. Xu,et al.  Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. , 2011, Genes & development.

[21]  Yongsoo Kim,et al.  Galectin-3 maintains cell motility from the subventricular zone to the olfactory bulb , 2011, Journal of Cell Science.

[22]  M. Buckland,et al.  Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications , 2011, Journal of Clinical Pathology.

[23]  Rebecca A. Ihrie,et al.  Lake-Front Property: A Unique Germinal Niche by the Lateral Ventricles of the Adult Brain , 2011, Neuron.

[24]  R. Klose,et al.  The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases , 2011, EMBO reports.

[25]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[26]  J. Licht,et al.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.

[27]  Hai Yan,et al.  Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. , 2010, Journal of the National Cancer Institute.

[28]  G. Ming,et al.  Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination , 2010, Nature Neuroscience.

[29]  G. Reifenberger,et al.  The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation. , 2010, Genes & development.

[30]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[31]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[32]  D. Louis,et al.  Faculty Opinions recommendation of Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. , 2009 .

[33]  J. Huse,et al.  Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing , 2008, Brain pathology.

[34]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[35]  A. Álvarez-Buylla,et al.  Characterization of Adult Neural Stem Cells and Their Relation to Brain Tumors , 2008, Cells Tissues Organs.

[36]  C. Greer,et al.  Dynamic Contribution of Nestin-Expressing Stem Cells to Adult Neurogenesis , 2007, The Journal of Neuroscience.

[37]  Eric C. Holland,et al.  Mouse Models of Brain Tumors and Their Applications in Preclinical Trials , 2006, Clinical Cancer Research.

[38]  P. Dirks,et al.  Cancer stem cells in nervous system tumors , 2004, Oncogene.

[39]  G. Finocchiaro,et al.  L-2-hydroxyglutaric aciduria and brain malignant tumors , 2004, Neurology.

[40]  Catherine L Nutt,et al.  The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas , 2004, Journal of neuropathology and experimental neurology.

[41]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[42]  Eric C. Holland,et al.  Gliomagenesis: genetic alterations and mouse models , 2001, Nature Reviews Genetics.

[43]  O. Kretz,et al.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.

[44]  J. García-Verdugo,et al.  Cellular Composition and Three-Dimensional Organization of the Subventricular Germinal Zone in the Adult Mammalian Brain , 1997, The Journal of Neuroscience.

[45]  C. Lois,et al.  Long-distance neuronal migration in the adult mammalian brain. , 1994, Science.

[46]  Verena I Gaidzik,et al.  TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Jeffrey W. Clark,et al.  Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. , 2012, The oncologist.

[48]  Frank M. Sacks,et al.  IDH 1 and IDH 2 Mutations in Gliomas , 2009 .

[49]  M. Aghili,et al.  Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review , 2008, Journal of Neuro-Oncology.